Vital Signs - Contract Research Outsourcing: Market Trends  2010 & Beyond


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This issue of Vital Signs, released on November 1, 2010, provides a strategic overview of key issues and trends relating to contract research outsourcing. Additionally, a company spotlight is provided for Accelovance, a vaccine-focused CRO that has established itself in delivering an innovative and proven approach to accelerated clinical development. Reimbursement and regulatory news from the FDA is also provided for the week of October 11, 2010.

Table of Contents

Vital Signs - Contract Research Outsourcing: Market Trends – 2010 & BeyondVital Signs: 1 Nov 2010This week's issue:

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.